CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsHigh structural barrier to entry
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
661.20BKRW476.43M · vs all stocks (USD)
Trailing P/E
41.03xRevenue (TTM)
67.20BKRW48.43M · vs all stocks (USD)
Profit Margin
30.25%52-Week Change
156.73%vs all stocks
Market Capitalization
661.20BKRW476.43M · vs all stocks (USD)
Enterprise Value
582.21BKRW419.52M · vs all stocks (USD)
Trailing P/E
41.03xPEG Ratio
0.1779xPrice to Sales (TTM)
9.35xPrice to Book (MRQ)
8.31xEnterprise to Revenue
8.66xEnterprise to EBITDA
36.00xGross Margin
100.00%Profit Margin
30.25%Operating Margin
19.95%Return on Assets (TTM)
13.01%Return on Equity (TTM)
29.48%Revenue (TTM)
67.20BKRW48.43M · vs all stocks (USD)
Revenue per Share (TTM)
1.51KKRWUpdated Aug 20, 2026Quarterly Revenue Growth
150.60%Gross Profit (TTM)
67.19BKRW48.42M · vs all stocks (USD)
EBITDA (TTM)
14.25BKRW10.27M · vs all stocks (USD)
Net Income (TTM)
20.33BKRW14.65M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
241.90%Operating Cash Flow (TTM)
13.59BKRW9.79M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
4.95BKRW3.56M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
53.39BKRWFY2025 · Dec 31, 2025Gross Profit
53.39BKRWFY2025 · Dec 31, 2025Operating Income
12.62BKRW9.09M · vs all stocks (USD)
Pre-tax Income
13.72BKRWFY2025 · Dec 31, 2025Income Tax Expense
-2.06BKRWFY2025 · Dec 31, 2025Net Income
15.78BKRWFY2025 · Dec 31, 2025EBIT
13.74BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
14.25BKRWFY2025 · Dec 31, 2025Research & Development
9.72BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
28.25BKRWFY2025 · Dec 31, 2025Other Operating Expenses
153.73MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
1.39BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
11.68MKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
15.78BKRWFY2025 · Dec 31, 2025Operating Cash Flow
11.58BKRWFY2025 · Dec 31, 2025Free Cash Flow
11.28BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
47.05BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
15.78BKRWFY2025 · Dec 31, 2025Stock-based Compensation
696.53MKRWFY2025 · Dec 31, 2025Other Non-cash Items
-1.38BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-3.46BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-59.52MKRWFY2025 · Dec 31, 2025Capital Expenditures
-302.90MKRWFY2025 · Dec 31, 2025Purchase of Investments
-5.89BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-6.20BKRWFY2025 · Dec 31, 2025Other Financing Charges
-1.61BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-331.92MKRWFY2025 · Dec 31, 2025Shares Outstanding
44.89MSharesUpdated Aug 20, 2026Float Shares
22.70MSharesUpdated Aug 20, 2026% Held by Insiders
49.38%vs all stocks
% Held by Institutions
1.02%vs all stocks
Total Cash (MRQ)
57.31BKRW41.29M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.28KKRWUpdated Aug 20, 2026Total Debt (MRQ)
115.43MKRW83.17K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0014xCurrent Ratio (MRQ)
9.48xBook Value per Share (MRQ)
1.77KKRWUpdated Aug 20, 2026Total Assets
75.71BKRW54.55M · vs all stocks (USD)
Total Current Assets
63.84BKRWFY2025 · Dec 31, 2025Total Liabilities
3.67BKRWFY2025 · Dec 31, 2025Total Non-current Assets
11.87BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
44.53MKRWFY2025 · Dec 31, 2025Total Current Liabilities
3.62BKRWFY2025 · Dec 31, 2025Cash
47.05BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
47.05BKRWFY2025 · Dec 31, 2025Other Short-term Investments
5.69BKRWFY2025 · Dec 31, 2025Accounts Receivable
10.53BKRWFY2025 · Dec 31, 2025Accounts Payable
2.67BKRWFY2025 · Dec 31, 2025Short-term Debt
81.27MKRWFY2025 · Dec 31, 2025Other Current Liabilities
-270.00KRWFY2025 · Dec 31, 2025Long-term Debt
44.53MKRWFY2025 · Dec 31, 2025Common Stock (Book)
22.24BKRWFY2025 · Dec 31, 2025Retained Earnings
26.68BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
72.04BKRW51.91M · vs all stocks (USD)
52-Week Low
5.66KKRWUpdated Aug 20, 202652-Week High
28.90KKRWUpdated Aug 20, 202652-Week Change
156.73%vs all stocks
50-Day MA
13.36KKRWUpdated Aug 20, 2026200-Day MA
18.09KKRWUpdated Aug 20, 2026Avg 10-Day Volume
990.62KSharesUpdated Aug 20, 2026Avg 30-Day Volume
720.72KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
359.00KRWUpdated Aug 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 164.072
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Anhui Sunhere Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tuoxin Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jenscare Scientific Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chison Medical Technologies Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orthofix Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Hanbon Science & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Leadman Biochemistry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Transtek Medical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Yungshin Global Holding Corp.
Tier 1ProductionApproval-Gated PipelineRuleFlow
G2GBio Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Sai Microelectronics Inc.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Samg Entertainment Co., Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Filtronic Plc
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated